$EDSA Up 32%! 🚀 🔹 Edesa Biotech ripping after announcing new Phase 3 paridiprubart data selected for oral presentation 📈 🔹 Data will be featured at the ERA

$EDSA Up 32%! 🚀 🔹 Edesa Biotech ripping after announcing new Phase 3 paridiprubart data selected for oral presentation 📈 🔹 Data will be featured at the ERA Congress, putting its acute kidney injury program back in focus 🧬 🔹 Paridiprubart is also being studied in ARDS, with prior positive Phase…